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Resumo: 
 
A potenciação de longo termo (Long-term potentiation- LTP) é considerada a base 
neurofisiológica de diferentes tipos de memória, tal como a memória espacial. No envelhecimento, 
está bem descrito um défice da memória dependente do hipocampo, em função do aumento da 
idade, que é classicamente correlacionado com a diminuição da LTP.  
Estudos recentes no nosso laboratório, focados nos mecanismos da LTP na área CA1 de 
fatias de hipocampo de rato, demonstraram que a magnitude da LTP pode ser potenciada no 
envelhecimento. Contudo é crucial entender este paradoxo entre a LTP aumentada no 
envelhecimento e os défices de memória apresentados em animais velhos.  
Os receptores de glutamato do tipo NMDA são essenciais para a potenciação de longo 
termo na área CA1 do hipocampo.  
Curiosamente, apesar de ser uma antagonista parcial dos receptores NMDA, a memantina 
é um fármaco amplamente utilizado no tratamento da doença de Alzheimer com propriedades de 
melhoria cognitiva. Assim, utilizando este fármaco, estudámos de que forma a alteração da 
activação dos receptores NMDA poderia estar relacionada com o aumento da magnitude da LTP e 
os défices de memória observados em animais velhos.  
A memantina (10, 5 e 1 mg/kg/dia) ou um controlo salino foram cegamente administrados 
intraperitonealmente durante  14 dias a ratos machos wistar com  10-15 ou 70-80 semanas de 
idade. Foram usados ensaios comportamentais para avaliar a memória dependente de hipocampo 
(Morris Water Maze), a actividade locomotora (Open Field) e a ansiedade (Elevated Plus Maze). 
Potenciais pós-sinapticos excitatórios (fiel excitatory postsynaptic potentials- fEPSP) foram 
registados na área CA1 do hipocampo para avaliar a LTP e a transmissão sináptica basal. A LTP 
foi induzida por um protocolo θ-burst (4 bursts, 100Hz, 4 estimulos, separados por 200 ms) e a 
transmissão sináptica basal foi analisada por curvas Input-Output. Os níveis dos receptores AMPA 
(subunidade GluR1) e NMDA (subunidade 2B) foram quantificados por immunoblot.  
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A memantina apresentou um efeito dependente da dose em animais velhos. Para doses 
altas (10 mg/kg/dia) a memantina diminuiu a magnitude da LTP em 40.2% conduzindo à perda de 
memória dependente do hipocampo. Para doses moderadas (5 mg/kg/dia) é observada uma 
diminuição da magnitude da LTP de 21.7% sem afectar a aprendizagem. Em animais tratados com 
doses baixas (1 mg/kg/dia) não são observadas alterações quer na LTP quer na aprendizagem. A 
memantina em animais jovens não apresenta, independentemente da dose, efeitos tanto na LTP 
como na memória dependente do hipocampo. 
Não são observadas alterações na transmissão sináptica basal, em qualquer grupo de 
animais, bem como  nos níveis de receptores NMDA (subunidade 2B) e AMPA (subunidade 
GluR1). 
Em suma, estes resultados sugerem que a LTP aumentada em animais velhos é um 
fenómeno compensatório e não patológico. O crescente bloqueio da LTP, através de uma 
antagonista parcial dos receptores NMDA, conduz a prejuízo da aprendizagem ao invés de 
melhoria da aprendizagem, o que significa que a LTP aumentada é necessária para que os 
processos de aprendizagem ocorram. 
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Abstract: 
 
Hippocampal long-term potentiation (LTP) is considered the neurophysiological basis of 
different types of memory, such as spatial memory. In ageing, there is a well-documented age-
dependent decay of hippocampal dependent memory, which is classically associated with LTP 
impairments. Recent studies in our laboratory, focused on LTP mechanisms in the CA1 area of rat 
hippocampal slices, have shown that hippocampal LTP magnitude can also be enhanced upon 
ageing. Therefore it is crucial to understand this apparent paradox correlating the higher LTP to 
the memory deficits displayed by these aged animals.  
NMDA glutamate receptors are essential for CA1 hippocampal long-term potentiation. 
Interestingly, in spite of being a partial antagonist of NMDA receptors, memantine is a drug 
widely used in the treatment of Alzheimer’s disease, having cognitive enhancing properties. Thus, 
using this drug, we now studied whether changes on NMDA receptor activation could be related to 
the increased LTP magnitude and memory impairments observed in older animals.  
Memantine (10, 5 and 1 mg/kg/day) or saline vehicle were blindly intraperitonealy (ip) 
administrated for 14 days to 10-15 (young) and 70-80 (old) weeks old male Wistar rats. Behaviour 
assays were used to evaluate hippocampal dependent memory (Morris Water Maze), locomotor 
activity (Open Field) and anxiety (Elevated Plus Maze) across the different age groups and 
pharmacological treatments. Field-excitatory post-synaptic potentials were recorded from the CA1 
area of the hippocampus to evaluate LTP and basal synaptic transmission. LTP was induced by a 
θ-burst protocol (4 bursts, 100Hz, 4 stimuli, separated by 200 ms) and basal synatic transmission 
was analized through Input-Output Curves. The levels of GluR1 and NMDA(2B) subunits of 
glutamate receptors were quantified by immunoblot analysis.  
Memantine induces a dose dependent effect in old animals: for higher doses (10 
mg/kg/day) memantine decreases the LTP magnitude by 40.2%, and leads to hippocampal 
dependent memory impairments. For moderate doses (5 mg/kg/day) a decrease of 21.7 % in LTP 
is observed, whereas learning remains unchanged. The lower doses did not affect neither  LTP nor 
the learning performance. In contrast, the administration of memantine to young animals, did not 
change LTP or hippocampal dependent memory, regardless of the dosage. 
The basal synaptic transmission and the levels of AMPA (GluR1 subunit) and NMDA 
(subunit 2B) receptors were not affected in any of the age groups or dose. 
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Overall, these results suggest that the higher LTP observed in old animals is a 
compensatory phenomenon, rather that a pathological one. The age-dependent blockade of LTP by 
a partial antagonist of NMDA receptors, leads to learning deficits in spite of learning 
improvements, implies that the higher LTP observed may be required for the learning process to 
occur.
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Abreviations List: 
 
AD – Alzheimer´s Disease 
AMPA – L-α-amino-3-hydroxy-5-methylisoxazole- 4- propionate 
CaMKII - Calcium / Calmodulin-dependent Kinase II 
cAMP - Cyclic Adenosine Monophosphate 
CNS – Central Nervous System 
CREB - cAMP Response Element Binding protein 
EPM – Elevated Plus Maze 
fEPSP – field Excitatory Post-Synaptic Potential 
GABA – γ-Aminobutyric Acid 
GHS-R1A - Growth Hormone Secretagogue Receptor type 1A 
GluR1 – Glutamate Receptor 1 subunit of AMPA Receptor 
H3 - Histamine receptors subunit 3 
IP - Intraperitoneal 
LTP – Long-Term Potentiation 
MAPK - Mitogen-activated Protein Kinases 
mRNA – Messenger Ribonucleic acid 
MWM – Morris Water Maze 
NMDA – N-methyl-D-aspartic Acid Receptor 
OF- Open Field 
PKA- Protein Kinase A 
PKC - Protein Kinase C 
PVDF - Polyvinylidene Difluoride 
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1 - Introduction 
1.1 – Aging 
 
Aging is a complex process with a multifactorial origin. Different processes and 
homeostatic systems, with central roles in cellular physiology, have been identified as playing 
important roles in healthy aging. Among them are the mechanisms underlying synaptic plasticity, 
that ultimately modify the dynamic of the neural network that support cognition (Backman et al., 
2010; Bishop et al., 2010; Fenech, 2010; Lopez-Lluch et al., 2010). Changes in this processes and 
also in dentritic morphology can affect and promote many of the alterations observed in aging 
(Burke and Barnes, 2006; Luebke et al., 2010) such as decreased cellular connectivity (Bondareff 
and Geinisman, 1976; Geinisman et al., 1977; Wilson, 2005), calcium homeostasis dysfunction 
(Toescu and Vreugdenhil, 2010), changes in gene expression (Burke and Barnes, 2006) and also 
protein homeostasis (Douglas and Dillin, 2010). 
 
1.1.1- LTP and aging 
 
The molecular and physiological alterations observed in aging are associated to 
impairments in learning and memory processes that are recognized as one of the major features of 
the aging process (Diogenes et al., 2011; Zhang et al., 2006). Clearly, memory impairments in 
aging are not solely related to a loss of synaptic plasticity (Lynch et al., 2006), but instead there are 
multiple processes altered. In old rats there is no reported loss in hippocampal CA1 pyramidal 
cells (Rapp and Gallagher, 1996; Rasmussen et al., 1996). Most biophysical properties of 
pyramidal cells remain unchanged, such as the spontaneous firing rates of single cells (Barnes, 
2003). On the other hand, there is a decrease in the size of neuronal trees (which has been 
correlated with synaptic plasticity) (Burke and Barnes, 2006) and a decline in the expression of the 
protein and mRNA encoding for different NMDA receptor subunits (Bai et al., 2004; Magnusson, 
2000) (Clayton et al., 2002; Sonntag et al., 2000). 
Long-term potentiation (LTP) is considered a model for the basic mechanisms involved in 
memory formation (Bliss and Collingridge, 1993). LTP is characterized as a reinforcement of the 
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postsynaptic potential in response for a high frequency stimuli, where glutamate plays a central 
role (Lomo, 1966). Therefore, stimulation of a certain circuit will induce permanent changes that 
increase the efficiency of synaptic transmission in that same stimulated synapse. One of the main 
brain areas where synaptic plasticity has been best studied is the hippocampus, whose main circuit 
is glutamatergic. In basal conditions, glutamate activates several classes of metabotropic receptors 
and three major types of ionotropic receptors: α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate 
(AMPA), N-methyl-D-aspartate (NMDA) and kainate receptors (Figure 1.1.1.1). Ionotropic 
receptors are ligand gated ionic channels permeable to the monovalent cations Na+ and K+ and, 
depending on the subtype, also to the divalent cation Ca2+ (Danysz and Parsons, 2003). 
 
Figure 1.1.1.1 - Glutamate receptors and synaptic plasticity. The arrival of a series of impulses at 
the presynaptic terminal triggers the release of glutamate, which binds to glutamate receptors at the 
postsynaptic membrane. Once activated, AMPA and kainate receptors conduct sodium ions, which initiate 
postsynaptic depolarization. Membrane potential changes leading to the release of magnesium ions that block 
NMDA receptors. Calcium influx through NMDA channels sets off a chain of events that establish long-term 
potentiation. Kainate receptors at the presynaptic end also seem to facilitate synaptic transmission at specific 
synapses by augmenting neurotransmitter release. Abbreviations: AMPA, α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionate; CaMKII, calcium / calmodulin-dependent kinase II; CREB, cAMP response element 
binding protein; MAPK, mitogen-activated protein kinase; NMDA, N-methyl-D-aspartate; PKA, protein 
kinase A; PKC, protein kinase C. 
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AMPA receptors are largely impermeable to Ca2+ and participate in most forms of fast 
synaptic transmission (Danysz and Parsons, 2003). The kainate receptors are also involved in 
synaptic transmission. Although the contribution of this receptors is controversial they produce bi-
directional modulation of both excitatory and inhibitory transmission and in some cases may 
trigger also metabotropic cascades (Huettner, 2003). In contrast, NMDA receptors usually do not 
contribute to basal synaptic transmission and are only activated under certain conditions. These 
receptors have three major features: they present high permeability to Ca2+ ions; voltage-
dependently blockage by Mg2+ ions and a slow gating kinetics (Danysz and Parsons, 2003). 
When a LTP is induced by a high frequency signal (or convergence of several signals) 
that arrives to the glutamatergic synapse, this leads to a massive glutamate release which triggers a 
sequence of events described in Figure 1.1.1.1 (Danysz and Parsons, 2003). In these conditions, 
AMPA / kainate receptors are activated, while NMDA receptors remained blocked by Mg2+. The 
continuous activation of AMPA / kainate receptors leads to a significant influx of Na2+ ions into 
the pos-synaptic cell, which in turn, decreases the membrane potential removing the Mg2+ ion from 
the blocked NMDA receptor. At this stage, Ca2+ ions can freely enter the cell via the NMDA 
receptor channel and initiate a number of enzymatic processes that lead to the permanent 
strengthening of synaptic transmission. This is manifested post synaptically as an enhancement of 
AMPA receptor sensitivity and number.  
 Classically it is stated that LTP magnitude is directly proportional to the learning ability, 
meaning that, a weak performance in the Morris Water Maze task is usually associated with a 
lower LTP magnitude (Lynch, 2004). However, there are data showing a lack of direct correlation 
between animals performance in Morris Water Maze tasks and LTP magnitude. Recently, data 
from the lab, demonstrate that hippocampal slices taken from old animals, which have an impaired 
hippocampal dependent memory when compared to younger animals, have an increased LTP 
magnitude induced by θ-burst stimulation (Diogenes et al., 2011). 
Hypothetically, the higher LTP together with the impairments in hippocampal dependent 
memory can be explained by an exacerbation of glutamate receptors activation. Excessive 
activation of these receptors would lead to a continuous Ca2+ influx into the cells, thus would 
ultimately result in neuronal damage, synaptic dysfunction or even cell death and consequent 
further decline of cognitive function in a mechanism similar to the already proposed for 
Alzheimer´s disease (AD) (Figure 1.1.1.2).  
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Figure 1.1.1.2 – It is hypothesized that in Alzheimer’s disease, due to the overactivation of the 
glutamatergic system, Mg2+ is no longer effective in its ability to control NMDA receptor activation (Danysz 
and Parsons, 2003). Abbreviators: Ca2+ - calcium ion. 
 
Although, the changes in LTP observed upon aging are controversial. Most of the studies 
describe that old animals present impairments in LTP that are specific for lower-intensity stimulus 
(Rosenzweig and Barnes, 2003). For high-frequency stimulation protocols (e.g. 100 Hz for 1 s) no 
age-related deficits are observed either in CA1 or Dentate gyrus both in vivo and in vitro (Barnes, 
1979; Diana et al., 1994a; Diana et al., 1994b; Landfield and Lynch, 1977; Landfield et al., 1978; 
Rosenzweig et al., 2003). 
These differences might be related to the type of stimulation protocol and the areas of the 
dendritic tree, particularly because age-related changes have been described in basal, but not 
apical, dendrites of CA1 pyramidal neurons (Lynch, 2004). 
Importantly, most of the alterations observed in healthy aging, namely those that lead to 
excitotoxicity, are also present in acute insults and in neurodegenerative diseases such as 
Alzheimer’s disease. 
 
1.2 – Memantine 
 
Aging increases the vulnerability to suffer from diseases such as cancer or 
neurodegenerative disorders as AD. AD begins with mild memory impairments and evolves into a 
major loss of cognitive abilities (Alloul et al., 1998).  
Currently the therapeutic approaches used in patients with AD are based on drugs that 
ameliorate cognitive symptoms such as the acetylcholinesterase inhibitors. Memantine (1-amino-3, 
5-dimethyladmantane), a partial antagonist of the glutamate NMDA receptors (Parsons et al., 
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1999), particularly of the 2B subtype is being used for the symptomatic treatment of AD since its 
safety and efficacy has been demonstrated (Chen and Lipton, 2006; McShane et al., 2006; Parsons 
et al., 2007; Rogawski and Wenk, 2003). Memantine with a molecular formula of C12H21N.HCl 
and a molecular weight of 215.77 g/mol is an uncompetitive NMDA receptor antagonist (IC50 of ~ 
3 µM) (Parsons et al., 1995). This drug presents good tolerability and is predicted to act selectively 
at NMDA receptors in vivo producing improvements in the therapy of dementia (Ditzler, 1991; 
Gortelmeyer and Erbler, 1992; Pantev, 1993) or on learning and memory (Lipton, 2006). 
However, memantine can produce psychotomimetic effects that appear only if the recommended 
titration of dosage from 5 to 20 mg over 3–4 weeks is skipped, or when memantine is combined 
with dopaminomimetic therapies (Parsons et al., 1997).  
However, it is well recognized that the blockade of NMDA receptors could lead to 
impairments of neuronal plasticity and learning (Collingridge and Bliss, 1995). In 1972, Merz and 
collaborators demonstrated that memantine  is effective in the central nervous system (CNS), 
revealing its potential for the treatment of Parkinson’s disease, spasticity and cerebral disorders 
like coma, cerebrovascular and geronto-psychiatric disturbances (Grossmann and Schutz, 1982; 
Miltner, 1982a, b; Mundinger and Milios, 1985; Schneider et al., 1984). 
Like Mg2+, memantine is able to dissociate from NMDA receptor channel due to its 
voltage-dependency and fast unblocking kinetics providing neuroprotection and symptomatic 
restoration of synaptic plasticity by the same mechanism. Neuroprotective agents which 
completely block NMDA receptors lead to impairments in normal synaptic transmission and 
thereby cause numerous side effects. The challenge has been to develop antagonists that prevent 
the pathological activation of NMDA receptors but allowing their physiological activity such as 
memantine (Figure 1.3.1). 
 
 
Figure 1.3.1 – Chemical structure of memantine: three-ring structure; bridgehead amine (–NH2 
group), which is charged at the physiological pH of the body (–NH3+) and represents the region of memantine 
that binds at or near the Mg2+ binding site in the N-methyl-D-aspartate receptor (NMDA receptors)-associated 
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ion channel; and methyl group (–CH3) side chains, which stabilize memantine interaction in the channel 
region of the NMDA receptors. Adapted from (Lipton, 2006). 
 
The promising profile of memantine has been attributed to its strong voltage dependency 
(inhibits NMDA-induced currents at -70mV, but does not affect NMDA-currents at +70 mV) to its 
rapid, open-channel unblocking kinetics (faster rates of channel unblock Koff = 0.2 sec-1) and also 
to its low to moderate affinity (with Ki of 0.5 - 0.7 µM) which would allow the blockade of only 
the pathological activation of NMDA receptors, leaving their physiological activation relatively 
intact (Chen et al., 1992; Ditzler, 1991; Frankiewicz et al., 1996; Parsons et al., 1993; Parsons et 
al., 1995). Besides its actions on NMDA receptors, memantine can also act as an antagonist of the 
nicotinic acetylcholine receptors and 5-HT receptors (Aracava et al., 2005; Buisson and Bertrand, 
1998). 
The rationale for using memantine in AD patients is based on the hypothesis that the 
blockade of NMDA receptor-mediated excitotoxicity can help to preserve neuronal structure and 
function (Lipton, 2006, 2007; Wenk et al., 2006). The improvement of memory in AD upon 
treatment is an apparent paradox concerning that as a NMDA receptor antagonist, memantine 
would impair the mechanisms underlying LTP and consequently hippocampal dependent memory.  
In this perspective, memantine could be an ideal tool to study the increased LTP observed 
in old animals. It would allow to test whether exacerbated activation of NMDA receptors could be 
related to the enhanced LTP magnitude and to the impaired hippocampal memory observed in old 
animals.  
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2 - Aim: 
 
Paradoxically, aging has been associated to a progressive impairment of hippocampal 
dependent memory together with an increase in hippocampal LTP (Costenla et al., 1999; Diogenes 
et al., 2011). These data are intriguing and could be a consequence of an overactivation of NMDA 
receptors, an already postulated hypothesis for the mechanism of several disorders such as 
Alzheimer´s Disease (Danysz and Parsons, 2003). We thus proposed to decipher if the increased 
LTP, detected in old animals, was an outcome of an exacerbated activation of NMDA receptors 
and whether it was a compensatory or a dysfunctional phenomenon (Figure 2.1). To achieve this 
we evaluated 1) whether an NMDA receptor antagonist, memantine, was able to restore 
hippocampal dependent memory in old animals, 2) if this was accompanied, by a reestablishment 
of the increased LTP and finally 3) which would be the molecular consequences of the chronic 
memantine treatment for NMDA (subunit 2B) and AMPA (subunit GluR1) receptors. 
 
 
 
Figure 2.1 – Possible effects of memantine upon aging. In A is represented what we have been observing 
regarding LTP magnitude, an increase on LTP magnitude with ageing. If this enhancement in LTP magnitude 
is a “dysfunctional LTP”, memantine would restore the normal (lower) LTP magnitude and improve learning 
and hippocampal dependent memory (B). If the higher LTP magnitude is a “compensatory LTP”, memantine 
would restore the normal (lower) LTP magnitude and aggravate the impairments in learning and hippocampal 
dependent memory (C).  
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3 - Techniques and Methods 
 
Experiments were performed with two age groups of Wistar rats (male, Wistar, Harlan 
Interfauna Iberica, SL, Barcelona, Spain): young (10–15 weeks), age at which reproductive 
behavior is fully established and old (70–80 weeks old) (Havenaar, 1993). The animals were kept 
under standardized temperature, humidity and lighting conditions, and had access to water and 
food ad libitum. All animal procedures were carried out according to the European Community 
Guidelines for Animal Care (European Communities Council Directive - 86/609/EEC).  
  
3.1 – Drugs 
  
1-amino-3, 5-dimethyladmantane (memantine) was diluted in a saline vehicle (0.9%). 
Memantine was generously provided by Grünenthal (Germany).  
 
3.2 - Intraperitoneal injection 
 
 Memantine 10, 5 or 1 mg/kg/day was blindly administrated intraperitonealy (Figure 3.2.1) 
as previously described (Anderson et al., 2004; Meisner et al., 2008; Reus et al., 2010). 
  
 
Figure 3.2.1 – Intraperitoneal injection: the immobilization procedure (A) and the local of the injection (B). 
A B 
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3.3- Behaviour Assays: 
 
3.3.1 - Open Field Test 
 
Background 
 
The Open Field test (OF) was originally described for the study of emotionality in rats 
(Hall, 1934). Nowadays it is mostly used to assess locomotor, exploratory and anxiety-like 
behaviour in laboratory animals (rats/mice).  
Open field is based on two concepts: individual testing (the animal is separated from its 
social group) and agoraphobia (as the arena is very large when comparing to the animal’s breeding 
or natural environment) (Prut and Belzung, 2003). The procedure consists in subjecting an animal, 
to an unknown environment (Walsh and Cummins, 1976) exploring the duality between the innate 
fear that rodents have of novel open and bright spaces versus their desire to explore new 
environments (Prut and Belzung, 2003).  
Different protocols of the open field are available (Prut and Belzung, 2003) both 
concerning the apparatus and the procedure. The Open Field area consists of an empty and bright 
square arena (67 x 67 x 52 cm), surrounded by walls to prevent animal from escaping (Figure 
3.3.1.1). The animal is usually placed at the center of the arena and the behaviour recorded over a 
chosen period of time (from 3 to 15 min) (Prut and Belzung, 2003), in one trial or multiples trials 
(Walsh and Cummins, 1976). Ambulatory locomotion in the horizontal plane is quantified by an 
observer or software that records the number of lines crossed or squares entered and this can be 
used to access anxiety. When anxious, the natural tendency of rodents is to stay preferably close to 
the walls (thigmotaxis). In this context, anxious-related behaviour is evaluated by the degree to 
which the rodent avoids the center of the OF (Crawley, 1985; Stone, 1932), measuring the 
percentage of time spent in the central of the arena (Prut and Belzung, 2003). Freezing behaviour, 
defined as the absence of movement, can also be assessed and is usually taken as indicative of a 
high-stress state. 
The spontaneous activity in the open field is the most standardized measure of motor 
function (Crawley, 1985). Changes in the locomotor performance can be evaluated by measuring 
the average speed or the travelling distances during a defined time interval. Behaviour of rodents 
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in the open field depends mainly on: tactile sensory factors as vibrissae (Prut and Belzung, 2003), 
lighting conditions and the light-dark cycle, field size (Blizard, 1971), apparatus colour and 
material (Delbarre et al., 1970; Oldham, 1970; Satinder, 1968), environmental odours and also on 
the start positions in the apparatus (Clark C. V. H., 1970; Clark, 1970; Satinder, 1969). 
 
 
Figure 3.2.1.1 – Open Field apparatus and zones defined with the software. 
 
 
Procedure: 
 
 Animals were gently placed in the center of the arena and the behaviour recorded for 5 
minutes. Travelling distance and average speed were recorded using PanLab software to evaluate 
the locomotor activity. Light, noise, smell and temperature were controlled. 
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3.3.2 - Elevated Plus Maze 
 
Background 
 
The elevated plus maze has its origin in the Y-shaped apparatus (Montgomery, 1958) and 
was latter modified into an elevated maze with four arms (two open and two closed) that are 
arranged to form a plus shape (Handley, 1984). This task is based on the conflict the rodent has 
between his preferences for staying in the closed, protected areas (thigmotaxis) and his innate 
motivation to explore the novel, open environments. This maze allows the evaluation of both anti-
anxiety behaviour, manifested as an increased time in the open arms, and motor activity, 
determined simultaneously by measuring spontaneous motor activity (total arm entries). Other 
ethological behaviours that can be measured in this maze are the number of rears, head dips, fecal 
boli, freezing or stretched-attend postures (Walf and Frye, 2007). This maze was validated by 
demonstrating that anxiogenic drugs reduce the time spent on the open arms and anxiolytic drugs 
increase the time spent on the open arms of the elevated plus maze (Pellow et al., 1985). 
Moreover, it has been shown that the increased open arms activity observed in rodents is 
correlated with increased central square entries in a brightly lit open field (Frye et al., 2000) and 
that the plasma corticosterone levels increase with open arms exposure and are positively 
correlated with risk assessment behaviour in the elevated plus maze (File et al., 1994; Rodgers et 
al., 1999). 
Pre-exposure to another testing environment does not alter subsequent behaviour of rats 
or mice in elevated plus maze (Walf and Frye, 2007). On the other hand recent reports suggest that 
the pre-exposure to the plus maze itself induces test decay and alters the subsequent response of 
the animal (File et al., 1990; Lister, 1987; Pellow et al., 1985), there are differences when rodents 
are exposed to the plus maze on more than one occasion (Adamec et al., 2004; Adamec et al., 
2006). Besides this the behaviour of rats and mice in the elevated plus maze can be influence by 
different parameters: circadian rhythms / light cycle (Andrade et al., 2003; Carobrez and Bertoglio, 
2005; Jones and King, 2001); handling of the animals such as prior experience with handling 
(Andrews and File, 1993; Brett and Pratt, 1990), stress (Steenbergen et al., 1990) or injections  
(Lapin, 1995); age  (Boguszewski and Zagrodzka, 2002); sex/gender (Imhof et al., 1993); strain 
(Rodgers and Cole, 1993); breeding line differences (Bert et al., 2001); estrous cycle (Marcondes 
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et al., 2001) and also differences in housing conditions and temperature of the room (21 ± 1ºC) 
(Zhu et al., 2006). 
 
 
Figure 3.2.2.1 – Elevated Plus Maze apparatus.  
 
Procedure:  
 
The maze consists of four arms (two open without walls and two enclosed) (Walf and 
Frye, 2007) 120 cm above the floor, each arm has 100 cm length, 10 cm width and 50 cm height 
(Figure 3.3.2.1). 
Animals were placed in the intersection of the arms facing an open arm and the behaviour 
was recorded during 5 minutes. The time spent in the open arms and the number of total entries 
were measured and used to evaluate the anxious behaviour and locomotion, respectively. The 
light, noise, smell and temperature were controlled. 
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3.3.3- Morris Water Maze 
 
Background 
 
The Morris water maze (MWM) task was described 30 years ago to study spatial learning 
and memory in laboratory rats (Morris, 1981). Learning is the acquisition of an altered behaviour 
due to an environmental stimulus; the animal changes its behaviour in response to an experience 
and stores a memory (Sweatt, 2003). 
Spatial learning is an example of hippocampal-dependent learning, both in humans and 
lower animals. Animals must learn to navigate their environment and learn to associate particular 
places with particular items or events (Sweatt, 2003) generating a “cognitive map” (allocentric 
visuospatial cues) (Hodges et al., 1995). This type of learning has been defined to be hippocampal 
dependent. A wide variety of different studies have shown that molecular or anatomical lesions of 
the hippocampus lead to spatial learning deficits in both humans and lower animals. Also, direct 
measurements of a wide variety of molecular and physiologic changes have been shown to 
correlate with hippocampal dependent spatial learning (Sweatt, 2003), such as Long-term 
Potentiation and NMDA receptor function (Bannerman et al., 1995; Morris et al., 1986; Moser and 
Moser, 1998). 
 The Morris water maze is a hippocampal-dependent spatial learning task in which 
animals are required to learn how to locate an escape platform in a swimming pool, using visual 
cues that are surrounding the maze (Sweatt, 2003). The device consists of a large circular pool 
filled with opaque water that is positioned in a room with a sufficient amount of external cues 
visible to the swimming animal.  
During the acquisition days, animals learn how to find the platform and escape from the 
pool (D'Hooge and De Deyn, 2001) using a random or semi-random set of start locations (Vorhees 
and Williams, 2006). This period consist at a minimum of 4 days, in each day the animals perform 
4 trials separated by at least 15 minutes (Diogenes et al., 2011) in which they are allowed to search 
the platform for 60 seconds. If the animal finds the platform, stays there for 10 seconds, otherwise 
is guided to the platform remaining there during 20 seconds to acquire the spatial location 
(Diogenes et al., 2011). The acquisition days should be performed until the control condition is in 
steady phase different of learning, having all the same latency (time to find the platform). 
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Variation to the test can include a visible platform or different inter trail intervals (Rick et al., 
1996). 
To determine if the animals are using a spatial learning strategy to locate the escape 
platform, they are subjected to a “probe” trial after the train is completed. This test can be 
performed in the last day of the acquisition training or in following day. In the probe test the 
platform is removed and the animal is allow to swim freely for 60 seconds while recording the 
percentage of time spent in each quadrant.  
  Behaviour of animals in the Morris Water Maze can be influence by different parameters 
such as: body weight (Wenk, 2004), gender or strains/species (D'Hooge and De Deyn, 2001; Roof 
et al., 1993), age (Brandeis et al., 1989; D'Hooge and De Deyn, 2001; Gallagher and Nicolle, 
1993; Geinisman et al., 1995), nutrition (Pitsikas et al., 1990), stress (Grauer and Kapon, 1993) or 
infectious agents and parasites (Gibertini et al., 1995). Differences in the apparatus and training 
procedures can also modifie the behaviour of animals. Alterations of the basic training protocols 
(Stewart, 1993; Wenk et al., 1998) such as introducing a Visible-platform during acquisition 
training (e.g. by putting a flag on top of the platform) (Hauben et al., 1999; Rick et al., 1996; 
Vorhees and Williams, 2006) or performing a second probe trial (Vorhees and Williams, 2006) are 
often made. The presence and amount of the external cues (Stewart, 1993), the opacifier and the 
size of pool (Morris, 1984) can also change the animal behaviour. 
 
 
 
 
Figure 3.2.3.1 – Morris Water Maze apparatus (A) and representative tracing of probe test of one animal that 
learn where the platform was (B). 
 
 
 
A B 
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Procedure: 
 
 The Morris water maze apparatus consists in a circular pool (150cm diameter and 62 cm 
height) with a platform (12cm diameter and 42 cm height) submerged 1.5 cm beneath the water 
surface (Figure 3.3.3.1). The platform location was selected randomly for each animal but was 
kept constant throughout the training phase (Martinez-Coria et al., 2010). 
The rats were subjected to four training trials a day for 4 days with a intra trial interval at 
least 15 minutes. Retention of the spatial training was assessed 24 hours after the last training 
session (long-term memory), by measuring the time spent in the platform quadrant. The light, 
noise, temperature of the room and the water, colour of the water and constant distribution of the 
cues were controlled. 
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3.4- Extracellular electrophysiology recordings 
 
3.4.1 - Hippocampal slice preparation 
 
Background 
 
McIlwain and collaborators were pioneers in developing methods for ex vivo CNS 
preparations to perform biochemical studies (Mc et al., 1951). In 1957, Li and McIlwain published 
the first electrophysiological study performed in cortex slices (Li and Mc, 1957). In spite of these 
early reports, these biological preparations were only believed to maintain their normal 
physiological properties after the studies by Yamamoto and McIlwain (1966) and Richards and 
McIlwain (1967), showing that hippocampal slices, sectioned perpendicularly to the long axis of 
the hippocampus, maintained synaptic activity and that the evoked responses were similar to those 
recorded in vivo. Since then, slices of CNS are commonly used as experimental models in 
pharmacological, biochemical and neurophysiological studies. The hippocampus is used 
extensively in these techniques, (Anderson and Collingridge, 2001) since the arrangement of the 
neurons allows this brain structure to be sectioned such that most of the relevant circuitry is left 
intact presenting a unique laminated organization. The cell bodies of the pyramidal neurons lie in a 
single packed layer that is easily visualized and is possible to distinguish the different areas that 
constitute the hippocampal circuit. The hippocampus can be divided in three main areas that 
communicate mainly through an unidirectional circuit that projects from the Dentate Gyrus to CA3 
and this to CA1.   
 
 
  
 
A B C 
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Figure 3.3.1.1 – A) Illustration of rat brain, B) hippocampus dissection, C) Chopper used to cut hippocampal 
slices and D) camera where the slices recovered energetically before recording. 
 
 
Procedure: 
 
Animals were sacrificed by decapitation under deep halothane anaesthesia. The 
hippocampi were isolated in ice-cold Krebs solution (Figure 3.4.1.1 A, B) with the following 
composition (mM): NaCl 124, KCl 3, NaHCO3 26, Na2HPO4 1.25, MgSO4 1, CaCl2 2, glucose 10, 
gassed with a 95% O2 + 5% CO2 mixture with pH 7.4. One hippocampus was used for 
electrophysiological recordings (Figure 3.4.1.1 C, D) and the other for receptor quantification 
through Western blot. 
 
   
D 
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3.4.2 - LTP induction 
 
Background 
 
 The first theories regarding the cellular basis of learning were postulated by Hebb, 
suggesting that information storage is achieved by activity-dependent alterations at the synapse 
(Hebb, 1949). Latter in 1973 Bliss and Lomo described a phenomenon they termed “Long-Term 
Potentiation” (LTP) (Bliss and Lomo, 1973). They reported that brief periods of high-frequency 
(100Hz) synaptic stimulation could lead to a permanent enhancement of synaptic transmission in 
hippocampal recordings from rabbits.  
 LTP can be induced by different protocols (Sweatt, 2003) and in different synapses. In the 
hippocampus, most of the experiments to study the basic processes underlying LTP have been 
performed at the synapse connections between axons from CA3 pyramidal neurons that extend 
into CA1, the schaffer-collateral synapses (Sweatt, 2003), by recording in the dendrite regions of 
CA1. 
 In extracellular recordings a field excitatory post-synaptic potential (fEPSP) is obtained. 
It results from the depolarization of the recording cells as a consequence of the glutamate release, 
induced by the electrical stimulation. The typical waveform of the fEPSP consists of a “fiber 
volley” and after the excitatory postsynaptic potential (EPSP) itself. The “fiber volley results from 
the presynaptic action potential arriving at the recording site, while the EPSP is the manifestation 
of the synaptic activation (depolarization) in CA1 pyramidal neurons. To evaluate changes in the 
fEPSPs, the parameter typically measured is the initial slope of the EPSP waveform. Absolute 
peak amplitude of the fEPSP can also be measured, but the initial slope is the preferred index since 
it is less prome to contamination from other sources of current flow in the slice (Sweatt, 2003).  
 
 
S1
S2
DG
CA3
CA1
 
A B C 
0.5 mV 
5 mV 
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Figure 3.4.2.1 – A) Photography of the recording chamber where slices are placed, B) Illustration of the 
hippocampus slice and where the stimulation (S1 and S2) and recording electrodes are localized. C) Tracing 
obtained after stimulation composed by the stimulus artifact, followed by the presynaptic volley and the 
fEPSP.   
 
Procedure:  
 
 Individual slices were transferred into a recording chamber continually superfused with 
Krebs solution at a constant flow (3 ml/min) and temperature (31ºC) with the same gassed solution 
(Figure 3.4.2.1 A). fEPSPs were recorded thought a microelectrode filled with NaCl 4M (2-6 MΩ 
resistance) and placed in CA1 stratum radiatum. Stimulation (rectangular 0.1-ls pulses, once every 
15 s) was delivered through a concentric electrode placed on the Schaffer collateral-commissural 
fibbers, in the stratum radiatum near the CA3-CA1 border (Figure 3.4.2.1 B) (Diogenes et al., 
2007). The protocol for LTP induction was a θ-burst stimulation (4x4: 4 bursts, 100Hz, 4 stimuli, 
separated by 200 ms) as previously described (Costenla et al., 2011). The initial intensity of the 
stimulus was that eliciting 50% of the maximal response. Recordings were obtained with an 
Axoclamp 2B amplifier and digitized (Axon Instruments, Foster City, CA). Individual responses 
were monitored, and averages of eight consecutive responses (Figure 3.4.2.1 C) were continuously 
stored on a personal computer with the LTP program (Anderson and Collingridge, 2001).  
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3.4.3 - Basal Synaptic Transmission - Input / Output Curve 
  
 
Input-output curves were performed to evaluate the effect of memantine on basal synaptic 
transmission. 
The underlying principle of this protocol is to evaluate the changes in synaptic responses 
that result from a step by step increase in stimulus intensity. It starts with a stimulation that elicits 
no synaptic response and ends with one that cannot further increase the fEPSP slope. The output 
results allow the evaluation of the maximal response that can be elicited and also to compare the 
ability to increase the synaptic response to each intensity of stimulation. 
 
Procedure:  
 
fEPSP were recorded through an extracellular microelectrode (4M NaCl, 2-6 MΩ 
resistance) placed in stratum radiatum of CA1 area. Stimulation (rectangular 0.1 ms pulses, once 
every 15 s) was delivered through a concentric electrode placed on the Schaffer collateral-
commissural fibers, in stratum radiatum near CA3-CA1 border. The intensity of stimulus (80-
200µA) was initially adjusted to obtain a large fEPSP slope with a minimum population spike 
contamination (Diogenes et al., 2011).  
After obtaining a stable baseline for at least 15 min, the stimulus delivered to the slice 
was decreased until no fEPSPs was elicited. The stimulus was then successively increased by 20 
µA steps. For each stimulation, data from three consecutive averaged fEPSP (each average fEPSP 
is the computerized mean of eight individual fEPSP) were stored. The range of stimulation was 
from 60 µA until 360 µA. The input-output curve was plotted as the relationship of the fEPSP 
slope vs stimulus intensity (e.g, fiber volley amplitude), which provides a measure of synaptic 
efficiency. 
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3.5 - Western Blotting 
 
Background: 
 
 The method was originally described in the laboratory of George Stark at Stanford 
(Burnette, 1981). 
 The first step in a Western blotting procedure is to separate the macromolecules using gel 
electrophoresis (Figure 3.5.1). After separated, proteins are transferred or blotted onto a second 
matrix, generally a nitrocellulose or polyvinylidene difluoride (PVDF) membrane (Figure 3.5.2). 
The membrane is then blocked, to prevent any nonspecific binding of antibodies to the surface of 
the membrane, and incubated with a primary antibody that recognizes the desired protein. The 
detection is made through an enzyme-labelled secondary antibody that recognizes specifically the 
primary antibody. An appropriate substrate is then added to the enzyme producing a detectable 
product such as light or a chromogenic precipitate. The intensity of the signal correlates with the 
abundance of the antigen on the membrane. 
 
 
 
 
Figure 3.5.1 - Discontinuous SDS-PAGE electrophoresis procedure. Samples are first loaded into wells in the 
gel, with one lane being usually reserved for a marker or ladder (commercially available mixture of proteins 
of defined molecular weights, stained to form visible, coloured bands). When voltage is applied, proteins 
migrate into the gel it at different speeds, according to molecular weight, causing smaller proteins to progress 
further along the gel. Image source: imb-jena.de. 
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Figure 3.5.2 - Protein Blotting procedure. In a typical wet blot, a sandwich structure is placed in a tank filled 
with transfer buffer. Proteins migrate from the negative (gel) to the positive (membrane) pole. Picture source: 
komabiotech.co.kr. 
 
Procedure: 
 
Hippocampi were disrupted in sucrose-Tris solution (0.32M sucrose solution with 50 mMTris 
supplemented with protease inhibitor (ROCHE) with a Teflon pestle and protein concentrations 
were determined using the Bio-Rad protein assay (Bradford, 1976). Total hippocampal proteins 
(60 or 45 µg) were denatured in sample buffer (10% (w/v) SDS, 600 mM DTT, 350mM Tris pH 
6.8, 30% (v/v) Glycerol and 0.012% Bromophenol Blue) at 95ºC for 5 minutes, fractionated on 8% 
SDS-polyacrylamide  electrophoresis gels and transferred onto polyvinylidene difluoride 
membranes (Millipore). Ponceau S staining was carried out to check the equal loading of the 
protein as well as the transfer to the membrane after blotting. After blocking with 5% non-fat dry 
milk in TBS-T 0,1% (Tris buffer saline solution, 200nM Tris, 1.5 NaCl with 0.1% Tween-20)  for 
1h, the blots were washed in TBS-T and incubated overnight at 4ºC with primary antibodies 
diluted in BSA 3% in TBS-T (reactive to NMDA (2B subunit) and AMPA (GluR1 subunit) 
receptors and α-tubulin-loading control). After washing again with TBS-T membranes were 
incubated with the secondary antibodies in 5% non-fat dry milk in TBS-T for 1 hour at room 
temperature. Chemoluminescent detection was performed with ECL-PLUS western blot detection 
reagent (GE Healthcare) using X-Ray films (Fujifilm). Optical density was determined with 
Image-J software and normalized to the respective α-tubulin density. 
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Table 3.5.1 – Primary and secondary antibodies and related conditions used in Western Blot experiments for 
individual proteins. All primary antibodies were diluted in 3% Bovine Serum Albumin with 0.1% NaN3 and 
secondary antibodies in 5% non-fat dry milk. 
 
Protein Protein 
Loading (µg) 
Primary 
antibody 
Animal Dilution Secondary 
antibody 
Dilution 
GluR1 45 Milipore 
(05-855) 
Rabbit 1:5000 Sta. Cruz 
Biotechno
logy (goat 
anti-
rabbit) 
1:10000 
NMDA
(2B) 
receptor 
60 Cell 
Signalling 
(D15B3) 
Rabbit 1:5000 1:10000 
 
3.6 - Statistics  
 
 The values presented are mean ± SEM of n experiments. To test the significance of the 
differences between vehicle and memantine groups, an ANOVA was used, with age group (young, 
old) and memantine dosage (vehicle, 1, 5, 10) as between-subject factors. Values of P<0.05 were 
considered to be statistically significant.  
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4 - Results 
4.1 - Behaviour assays: 
 
To study the behaviour alterations induced by memantine, the open field arena, the 
elevated plus maze and the Morris water maze test were performed.  
4.1.1 - Open Field 
 
Motor control is mainly integrated by striatal areas that receive multiple glutamatergic 
inputs. Given that NMDA receptor antagonists can influence motor control (Kang et al., 2011; 
Lemay-Clermont et al., 2011), the open field test was performed to evaluate the impact of 
memantine on locomotor behaviour of the animals treated with this drug. Animal average speed 
was evaluated for 5 minutes and the behaviour compared between different groups. 
The locomotor activity was significantly decreased (F(1.18) = 25.6, p< 0.001, ηp2 = 0.6) 
in old animals treated with saline vehicle (OFOldvehicle: 9.7 ± 0.4 cm/sec, n=10) when compared to 
the younger animals (OFYoungvehicle 13.4 ± 0.6 cm/sec, n=10, figure 4.1.1.1). 
Overall, memantine significantly affected locomotor activity in young (F(2.17) = 4.9, 
p<0.05, ηp2 = 0.4) and in old (F(2.17) = 16.3, p<0.001, ηp2 = 0.7) animals.  In younger animals, 
memantine (10 mg/kg/day) significantly increased locomotor behaviour (95% C.I.]0.5; 5.8[; p< 
0.05 by increasing the average speed in open field test in younger rats (OFYoungmemantine10mg/Kg: 16.5 
± 0.9 cm/sec, n=5 versus OFYoungvehicle: 13.4 ± 0.6 cm/sec, n=10). In old animals memantine 10 
mg/Kg/day also produced the same significant effect (95% C.I. ]0.4;4.2[; p< 0.05;  
OFOldmemantine10mg/Kg: 12.0 ± 0.6 cm/sec, n=5 versus OFOldvehicle: 9.7 ± 0.4 cm/sec, n=10; figure 
4.1.1.1).  
 Regarding the dosage of 5 mg/Kg/day, memantine only affected older animals (95% 
C.I.]0.6;4.5[; p<0.01). Old animals treated with 5 mg/Kg/day of memantine had a decreased 
average speed when compared to old vehicle treated animals (OFOldmemantine: 7.2±0.6 cm/sec; n=5 
versus OFOldvehicle: 9.7 ± 0.4 cm/sec; n=10, Figure 4.1.1.1). 
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 Besides the effects in motor behaviour, the higher dose memantine (10 mg/kg/day) also 
induced alterations of "natural behaviour" in young rats characterized by standing on hind legs, 
open-mouthed tooth display, long ‘eeeps’ without biting other rats.  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1.1.1 – Average speed evaluated in the locomotor test of the open field arena of young (black) and 
old rats (blue) treated with different doses of memantine (10 and 5mg/Kg/day (solid bars)) or vehicle (open 
bars) for 14 days. Results are mean ± SEM of the number of experiments (n): n youngvehicle = 10, nyoung5mg/kg = 5, 
nyoung10mg/kg = 5, noldvehicle = 10, nold5mg/kg = 5, nold10mg/kg = 5. The data were analyzed using a 2 X 2 ANOVA, 
with Age Group (young, old) and Memantine Dosage (0, 5, or 10 mg) as between-subject factors. *P<0.05 
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4.1.2 - Elevated Plus Maze 
 
Glutamate is ubiquitous within the central nervous system and has been shown to play 
important roles in many brain processes, including stress response and anxiety disorders (Drevets 
et al., 1997).  Exposure to severe stress has been associated with glutamate excitotoxicity. In fact, 
there are data demonstrating that antagonists of NMDA receptors have anti-anxiety effects 
(Campeau et al., 1992; Fendt et al., 1996). Therefore, we considered important to assess whether 
this pharmacological treatment had any impact on anxious behaviour. Consequently the animals 
were submitted to the elevated plus maze test and the time spent in the open arms was measured 
and compared between animals. 
The anxiety behaviour was not affected by ageing (Figure 4.1.2.1). Moreover, both young 
and old animals treated with memantine (10, 5, 1 mg/kg/day) did not show significant anxiolitic 
effects (Figure 4.1.2.1). However, in old animals treated with memantine, a strong tendency for an 
anti-anxiogenic behaviour was detected.   
 
 
 
 
 
 
 
 
Figure 4.1.2.1 – Time in open arms evaluated in the anxiety test of the Elevated plus maze aparratus of young 
(black) and old rats (blue) treated with different doses of memantine (10, 5 and 1 mg/Kg/day (solid bars)) or 
vehicle (open bars) for 14 days. Results are mean ± SEM of the number of experiments (n): nyoungvehicle = 13, 
nyoung1mg/kg = 5, nyoung5mg/kg = 12, nyoung10mg/kg = 5, noldvehicle = 13, nold1mg/kg = 7, nold5mg/kg = 9, nold10mg/kg = 5. The 
data were analyzed using a 2 X 3 ANOVA, with Age Group (young, old) and Memantine Dosage (0, 1, 5, or 
10 mg) as between-subject factors. *P<0.05 between the groups.  
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4.1.3 - Morris Water Maze 
 
 Memantine or saline vehicle were administered chronically for 14 days and the effects on 
learning and hippocampal dependent memory were evaluated using the Morris water maze test. 
Learning was assessed during acquisition, while the animals were taught to find the platform. 
Memory retrieval was evaluated at the probe test, by the time spent in platform quadrant.  
 Old animals showed an impairment on hippocampal dependent memory when compared 
with young animals F(1.23) = 10.9, p < 0.005, ηp2 = 0.3 (Figure 4.1.3.1 A). 
 When given in the higher dose, memantine (10 mg/kg/day), impaired learning in old 
animals (95% C.I. ]4.03; 24.0[; p< 0.05, n=13). That is visible during acquisition where old 
animals with memantine treatment take longer to find the platform comparing to vehicle treated 
rats (Figure 4.1.3.1 C). For lower doses of memantine (5 or 1mg/kg/day) no significant changes 
are observed in the learning performance of either young or old animals (Figure 4.1.3.1 D-G)  
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Figure 4.1.3.1 – Latency evaluated in Morris Water Maze test of the pool apparatus of young (black) and old 
rats (blue)  treated with different doses of memantine (10, 5 and 1 mg/Kg/day (solid bars)) or vehicle (open 
bars) for 14 days. Results are mean ± SEM of the n of experiments: nyoungvehicle = 13, nyoung1mg/kg/day = 6, 
nyoung5mg/kg/day = 14, nyoung10mg/kg/day = 5, noldvehicle = 13, nold1mg/kg/day = 7, nold5mg/kg/day = 14, nold10mg/kg/day = 5. The 
data were analyzed using a 2 X 3 X 4 mixed ANOVA, with Age Group (young, old) and Memantine Dosage 
(0, 1, 5, or 10 mg) as between-subject factors and Day (1, 2, 3,4) as a within-subject factor. *P<0.05. 
 
 The probe test was performed after acquisition to assess the hippocampal dependent 
memory retrieval. In the probe test the platform is removed and the time spent in the platform 
quadrant is measured. No changes were detected in the time spent in platform quadrant for treated 
groups when compared with vehicles (Figure 4.1.3.2).  
Young Old 
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Overall, it is possible to conclude that only in old animals and in the higher dose (10 
mg/kg/day) memantine impacts on the learning acquisition in the Morris Water Maze. 
 
 
 
  
   
 
 
 
 
 
Figure 4.1.3.2 – Time spent in quadrant in hidden platform in Morris Water Maze test of the pool apparatus 
of young (black) and old rats (blue)  treated with different doses of memantine (10, 5 and 1 mg/Kg/day (solid 
bars)) or vehicle (open bars) for 14 days. Results are mean ± SEM of the n of experiments: nyoungvehicle = 11, 
nyoung1mg/kg = 5, nyoung5mg/kg = 13, nyoung10mg/kg = 5, noldvehicle = 10, nold1mg/kg = 7, nold5mg/kg = 11, nold10mg/kg = 5. The 
data were analyzed using a 2 X 3 ANOVA, with Age Group (young, old) and Memantine Dosage (0, 1, 5, or 
10 mg) as between-subject factors.  
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4.2 – Extracellular electrophysiology recordings 
 
 
4.2.1 – Input/output curve 
 
Input Output curves were performed to evaluate changes in basal synaptic transmission 
that could result from the chronic blockade of NMDA receptors. 
As previously demonstrated (Diogenes et al., 2011), no differences were observed in the 
input output curves between young and old animals (Figure 4.2.1.1 A). Regarding memantine 
treatment, no significant changes were detected in the basal synaptic transmission of neither young 
nor old animals (Figure 4.2.1.1 B-G). 
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Figure 4.2.1.1 – Input–output curves obtained from young and old rats. Input–output curves are displayed as 
the relationship between fEPSP slope (ordinates) and stimulus intensity (measured as the amplitude of the 
pre-synaptic volley, in the abscissa) in the two age groups. After obtaining a stable baseline for at least 15 
min, the input delivered to the slice was decreased until the slope of the fEPSP was zero. Afterwards, the 
current delivered to the slice was increased by steps of 20 mA at the time, with three data points collected at 
Young Old 
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each stimulation amplitude (each data point being the average of eight individual fEPSP). The range of all the 
input delivered to the slice was typically from 60 mA to a supra-maximum intensity amplitude of 360 mA. 
For each age group, the data are mean ± SEM (both of fiber volley and fEPSP slope in each data point) of 
minimum n=3 slices taken from different animals. In A) are shown the fEPSP slopes in function of the fiber 
volley amplitudes over the stimulation measure the basal synaptic transmission, which was performed after 
the acquisition period for young (open dark (n=7) dots) and old (open blue (n=8) dots) animals vehicles. In B) 
and C) are shown the fEPSP slopes in function of the fiber volley amplitudes over the stimulation measure 
the basal synapse transmission, which was performed after the acquisition period for young (B) and old (C) 
animals, treated with 10 mg/kg/day of memantine (black (n=5) and blue (n=3) dots) or with vehicle (open 
dark (n=7) and open blue (n=8) dots). In D) and E) are shown the fEPSP slopes in function of the fiber volley 
amplitudes over the stimulation measure the basal synapse transmission, which was performed after the 
acquisition period for young (D) and old (E) animals, treated with 5 mg/kg/day of memantine (black (n=3) 
and blue (n=4) bars) or with vehicle (open dark (n=7) and open blue (n=8) dots). In F) and G) are shown the 
fEPSP slopes in function of the fiber volley amplitudes over the stimulation measure the basal synapse 
transmission, which was performed after the acquisition period for young (F) and old (G) animals, treated 
with 1 mg/kg/day of memantine (black (n=3) and blue (n=4) dots) or with vehicle (open dark (n=7) and open 
blue (n=8) dots). Results are mean ±SEM of the number of experiments. The data were analyzed using a 2 X 
3 X 4 mixed ANOVA, with Age Group (young, old) and Memantine Dosage (0, 1, 5, or 10 mg) as between-
subject factors and Day (1, 2, 3,4) as a within-subject factor. *P<0.05 . 
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4.2.2 – Long term Potentiation (LTP)  
 
 As mentioned before, data from the laboratory have been demonstrating an increase on 
LTP magnitude in old animals (Costenla et al., 1999, Diógenes et al., 2011). The present results 
corroborate the previous results, LTP magnitude recorded from hippocampal slices taken from old 
animals was significantly higher F(1.13) = 38.5, p< 0.001, ηp2 = 0.7 (LTPoldvehicle: 69.3 ± 3.7%, 
n=7) than LTP recorded in slices from young rats (LTPyoungvehicle: 36.9 ± 3.2% , n=5, Figure 4.2.2.1 
A).  
Memantine (10mg/kg/day) decreased LTP magnitude in hippocampal slices from old rats 
(95% C.I. ]16.2; 65.5[; p< 0.001; LTPold10mg/kg: 28.4 ± 6.2%;  LTPoldvehicle: 69.3 ± 3.7%; Figure 
4.2.2.1 B-E). For the intermediate dose, 5mg/kg/day, memantine only had a significant impact in 
LTP magnitude in old animals (95% C.I. ]2.3; 41.0 [; p< 0.05; LTPold5mg/kg: 47.6 ± 4.8% ; 
LTPoldvehicle: 69.3 ± 3.7; Figure 4.2.2.1 F-G). While for the lower dose (1 mg/kg/day), memantine 
had no significant effect on LTP magnitude neither in young nor in old rats (Figure 4.2.2.1 I-L). 
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Figure 4.2.2.1 – θ-Burst induced long-term potentiation (LTP). In (A-G) are shown the averaged time courses 
changes in field excitatory post-synaptic potential (fEPSP) slope induced by a θ-burst stimulation. The 
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ordinates represent normalized fEPSP slopes, where 0% corresponds to the averaged slopes recorded for 14 
min before θ-burst stimulation and the abscissa represents the time of recording. In A) field excitatory pos-
synaptic potentials over the time, for young (open dark (n=6)) and old (open blue, (n=9) dots) treated with 
saline vehicle are shown. In B) and C) field excitatory pos-synaptic potential over the time for young (B) and 
old (C) animals, treated with 10 mg/kg/day of memantine (black (n=3) and blue (n=4) dots) or with vehicle 
(open dark (n=6) and open blue (n=9) dots) are represented. In D) and E) field excitatory pos-synaptic 
potential over the time for young (D) and old (E) animals, treated with 5 mg/kg/day of memantine (black 
(n=6) and blue (n=9) dots) or with vehicle (open dark (n=6) and open blue (n=9) dots) are shown. In F) and 
G) field excitatory pos-synaptic potential over the time for young (F) and old (G) animals, treated with 1 
mg/kg/day of memantine (black (n=5) and blue (n=8) dots) or with vehicle (open dark (n=6) and 
open blue (n=9) dots) are shown. Representative traces from representative experiments are shown 
in the right panels in (A-G); each trace is the average of eight consecutive responses obtained 
before (1) and 46–60 min after (2) LTP induction, and is composed of the stimulus artifact, 
followed by the pre-synaptic volley and the fEPSP. In H) The Average of the last 13.3 minutes of 
the field excitatory pos-synaptic potential of the all groups of ages and treatment. Results are mean 
±SEM of the number of experiments. The data were analyzed using a 2 X 3 X 5 mixed ANOVA, 
with Age Group (young, old) and Memantine Dosage (0, 1, 5, or 10 mg) as between-subject 
factors and LTP Magnitude (56, 57, 58, 59, 60) as a within-subject factor. *P<0.05. 
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4.3 – Western Blotting results 
  
NMDA (2B) receptors are the major target for memantine (Johnson and Kotermanski, 
2006). Therefore, the alterations in the levels of NMDA receptors containing the 2B subunit were 
evaluated by western blotting. No changes were  detected in NMDA (2B) receptors in the 
hippocampus of young and old animals with memantine or vehicle (Figure 4.2.2.1 A-F). 
In addition to the NMDA receptors, AMPA receptors are also required for CA1 
hippocampal LTP in particular the GluR1 subunit of the AMPA receptors. Thus, changes in the 
pool of AMPA receptors containing GluR1 subunit could influence the magnitude of LTP 
(Andrasfalvy et al., 2003). Therefore, the analysis of the total GluR1 immunoreactivity on 
hippocampal homogenates was preformed.  No significant changes were detected in the levels of 
hippocampal GluR1 subunit of AMPA receptors in old rats when compared to younger animals. 
Moreover, memantine did not significantly influence the levels of GluR1 subunit of AMPA 
receptors either administrated to young or old animals (Figure 4.3.2).  
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Figure 4.3.1 – Expression levels of N-Methyl-D-aspartic acid receptors (NMDA receptors - subunit 2B) in the 
two age groups. In (B, D, F) are shown the western blots of NMDA receptors (180 kDa) and α-tubulin (55 
kDa, loading control), in homogenates of rat hippocampus taken from young  rats, as indicated above each 
lane. In (C, E, G) are shown the western blots of NMDA receptors  and α-tubulin , in homogenates of rat 
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hippocampus taken from old  rats, as indicated above each lane. In A) the averaged of NMDA receptors 
levels for young (open dark (n=5)) and old (open blue (n=5) bars) animals vehicle. In B) and C) the averaged 
of NMDA receptors levels for young (B) and old (C) animals, treated with 10 mg/kg/day of memantine (black 
(n=4) and blue (n=5) bars) or with vehicle (open dark (n=5) and open blue (n=5) bars). In D) and E) the 
averaged of NMDA receptors levels for young (D) and old (E) animals, treated with 5 mg/kg/day of 
memantine (black (n=5) and blue (n=5) bars) or with vehicle (open dark (n=5) and open blue (n=5) bars). In 
F) and G) the averaged of NMDA receptors levels for young (F) and old (G) animals, treated with 1 
mg/kg/day of memantine (black (n=3) and blue (n=3) bars) or with vehicle (open dark (n=3) and open blue 
(n=3) bars). The hippocampus homogenates were prepared from hippocampal slices taken from the same 
animals that were used in electrophysiological experiments. Results are mean ±SEM of the number of 
experiments. The data were analyzed using a 2 X 3 ANOVA, with Age Group (young, old) and memantine 
Dosage (0, 1, 5, or 10 mg) as between-subject factors. *P<0.05. 
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Figure 4.3.2 – Expression levels of one subunit of the 2-amino-3-(5-methyl-3-oxo-1,2,-oxazol-4yl) propanoic 
acid receptors (GluR1) in the two age groups. In (B, D, F) are shown the representative western blots of 
GluR1 (106 KDa) and α-tubulin (55 kDa, loading control), in homogenates of rat hippocampus taken from 
young rats, as indicated above each lane. In (C, E, G) are shown the western blots of GluR1 (106 KDa) and α-
tubulin, in homogenates of rat hippocampus taken from old rats, as indicated above each lane. In A) the 
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averaged of GluR1 (106 KDa) levels for young (open dark (n=5)) and old (open blue (n=5) bars) animals 
vehicle. In B) and C) the averaged of GluR1 (106 KDa) levels for young (B) and old (C) animals, treated with 
10 mg/kg/day of memantine (black (n=4) and blue (n=5) bars) or with vehicle (open dark (n=5) and open blue 
(n=5) bars). In D) and E) the averaged of GluR1 (106 KDa) levels for young (D) and old (E) animals, treated 
with 5 mg/kg/day of memantine (black (n=5) and blue (n=5) bars) or with vehicle (open dark (n=5) and open 
blue (n=5) bars). In F) and G) the averaged of GluR1 (106 KDa) levels for young (F) and old (G) animals, 
treated with 1 mg/kg/day of memantine (black (n=3) and blue (n=3) bars) or with vehicle (open dark (n=3) 
and open blue (n=3) bars). The hippocampus homogenates were prepared from hippocampal slices taken 
from the same animals that were used in electrophysiological experiments. Results are mean ± SEM of the 
number of experiments. The data were analyzed using a 2 X 3 ANOVA, with Age Group (young, old) and 
Memantine Dosage (0, 1, 5, or 10 mg) as between-subject factors. *P<0.05. 
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Table 4.1 – Summary of the obtained results. 
 
 Young Old 
1  
mg/Kg/day 
5  
mg/Kg/day 
10 
mg/Kg/day 
1  
mg/Kg/day 
5  
mg/Kg/day 
10  
mg/Kg/day 
Locomotor 
Behaviour 
? - ↑ ? ↓ ↑ 
Anxiety - - - - - - 
Spacial 
hippocampal 
dependent memory 
- - - - - ↓ 
Basal Synaptic 
transmission 
- - - - - - 
Magnitude of long 
term potentiation 
- - - - ↓ ↓ 
NMDA (2B) 
receptor 
immunorreactivity 
- - - - - - 
GluR1 receptor 
immunorreactivity 
- - - - - - 
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5 – Discussion 
 
Recent studies in our laboratory, focused on LTP mechanisms in the CA1 area of rat 
hippocampal slices, have shown that hippocampal LTP magnitude can also be enhanced in ageing. 
Therefore it was crucial to understand this apparent paradox correlating a higher LTP to memory 
deficits displayed by aged animals. Interestingly, in spite of being a partial antagonist of NMDA 
receptors, memantine is a drug widely used in the treatment of Alzheimer’s disease, having 
cognitive enhancing properties. Thus, using this drug, we now studied whether changes on NMDA 
receptor activation could be related to the increased LTP magnitude and memory impairments 
observed in older animals.  
The administration of memantine 10 mg/Kg/day caused a decrease on LTP magnitude in 
old animals, which is accompanied by a significant impairment of the learning performance. This 
together with the observation that a lower dose (5mg/Kg/day), despite decreasing LTP magnitude 
did not influence learning and memory, suggests that the higher LTP observed in old animals is 
not a dysfunctional phenomena and it might rather constitute a compensatory mechanism. 
The impact of memantine upon LTP, in all dosage regimes administered and in both age 
groups, is not an outcome of changes in basal synaptic transmission as assessed by input/output 
curves. 
Moreover, this work demonstrates that the age related changes on LTP and the effect of 
memantine are not a consequence of modifications of the total levels of NR2B and GluR1 subunits 
of NMDA and AMPA receptor respectively. Although the blockade of the NMDA receptors may 
lead to changes in the dynamic of the cells, decreasing the entry of Ca2+ ions (Chen et al., 1992), 
which could consequently lead to the incorporation of GluR1 receptors in the membrane without 
affecting the total levels of the receptors.  To further clarify if the present hypothesis is correct the 
levels of GluR1 receptors at a subcellular level should be evaluated. 
Given that NMDA receptor antagonists can influence motor control (Kang et al., 2011; 
Lemay-Clermont et al., 2011), the locomotor behaviour of the animals was evaluated.  Memantine, 
at the higher dose, induced a significant increase of the locomotor activity of young and old 
animals. NMDA receptor antagonists have been previously reported to induce alteration of the 
locomotion probably due to its affects on nucleus accumbens, on histamine receptors or directly by 
modulating the dopamine release in striatum (Adriani et al., 1998). One possible explanation to the 
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locomotor alterations observed for the higher dose is that memantine may be interfering with the 
accumbens, increasing dopamine release (Jerlhag et al., 2010) and thus locomotion. This 
hypothesis can be tested exploring the modulation by Ghrelin, the first endogenous ligand for the 
type 1A growth hormone secretagogue receptor (GHS-R1A) (Jerlhag et al., 2010).  Other 
hypothesis is the modulation of histamine receptors by NMDA receptor antagonists as described in 
other studies (Bardgett et al., 2009). The histamine receptors, namely H3 receptor, modulate 
dopamine and GABA in the basal ganglia, namely on an important subdivision, of the striatum, 
with a function in motor skills (Toyota et al., 2002). On the other hand, NMDA antagonists may be 
indirectly modulating dopamine in striatum (Adriani et al., 1998). 
Care must be taken when assessing memory tasks which depend on motor performance. 
However, we can exclude this confounding effect since we have observed an impairment of the 
latency to find the platform with memantine together with an enhanced mobility. In other hand, 
when the locomotion was decreased the hippocampal dependent memory remains unchanged.  If 
the learning deficits were due to motor effects, one would expect the opposite. ,It would be, 
however, more reliable to use also a behavior paradigm that evaluates hippocampal dependent 
memory independently of locomotion, such as the Barnes maze (Barnes et al., 1980). 
There are evidences that NMDA receptor antagonists could have anti-anxiety effects 
(Campeau et al., 1992; Fendt et al., 1996). In fact memantine showed a tendency to decrease the 
anxious behaviour in old animals. Anxiety was described to reduce latency to find the hidden 
platform and improve long-term memory of former location of platform without changing short-
term memory (He et al., 2011). This may indicate that this effect of memantine may be a factor 
interfering in learning in the Morris water maze.  
It is classically established that LTP in the hippocampus is a prototypical experimental 
model that translates into forms of learning and memory associated with that brain area (Lynch, 
2004), including spatial memory as assessed by the Morris water maze (Morris et al, 1982). 
Therefore, in order to correlate animal skills at hippocampal dependent learning and memory tasks 
with synaptic plasticity, LTP magnitude was recorded in hippocampal slices obtained from the 
same animals submitted to the behaviour tests.  Memantine in Alzheimer´s disease was approved 
as a drug with a positive impact in hippocampal dependent memory (Martinez-Coria et al., 2010). 
Although the NMDAR antagonists present a differential effects on LTP (Frankiewicz et al., 2000), 
memantine was chosen as a tool to decrease the long term potentiation because it has a binding 
pattern similar with Mg2+ ions, it is voltage dependent and presents fast kinetics and low affinity. 
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This drug acts by blocking partially NMDA receptors, being selective to extra-synaptic receptors 
and thus particularly useful to study excitotoxicity. Memantine, when administered chronically to 
old rats induces a concentration dependent decrease on LTP magnitude, which reaches a statistical 
significance for 5 and 10 mg/Kg/day. In young animals, in spite of a tendency for a decrease on 
LTP magnitude for 5 and 10 mg/Kg of memantine, this did not reach statistical significance. Only 
rats treated with the higher dose of memantine demonstrated an impairment in learning, that it is 
clearly observed in the learning curve. However, we could not detect changes in the probe test, 
which suggests that the animals have reached a similar retrieval performance. This could be 
investigated by performing a probe test earlier that on day 4 and check whether changes in probe 
test would be amplified. 
Given that both 5 and 10 mg/Kg/day of memantine decreased LTP magnitude in old 
animals, but only animals treated with the higher dose demonstrated significant changes in 
learning, this could mean that only by drastically affecting LTP (in our conditions, at least by 
50%) this would be translated into behavioural changes. This implies that the exacerbated LTP 
seen in aged animals is not a dysfunctional phenomenon, but may rather constitute a physiological 
adaptation. Moreover, the mechanism of action of memantine could change with the dose such as 
described by (Chen et al 1992). This could be an alternative possibility to the data obtained. The 
quantification of the levels of the drug in plasma would be useful to clarify if the in vivo 
concentration is the one at which memantine behaves as a partial antagonist of NMDA receptors.  
Overall, these results suggest that the higher LTP observed in old animals is a 
compensatory phenomenon, rather that a pathological one. The age-dependent blockade of LTP by 
a partial antagonist of NMDA receptors, that leads to learning deficit in spite of learning 
improvements, implies that the higher LTP observed may be required for the learning process to 
occur. 
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